Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Clinical Pathway for Alzheimer's Disease in China (CPAD): A 8-week Multi-center Registry Study to Investigate AD Diagnostic Pattern in Chinese Local Real Clinical Practice
Authors not listed
Peking University · 2012
Abstract
There are guidelines on the management of AD in China, the evidence adopted in the guidelines are mostly from the trials conducted in other countries due to very limited Chinese data available for local systematic review. Therefore, more local evidence on dementia care is needed for the development of an evidence-based guideline appropriate for people living in China. Meanwhile, the inadequate implementation of the current AD guideline, which results in the low diagnostic rate and high diagnostic leakage, may bring about extra barriers for AD patients to access dementia care service in different areas nationwide. However, there is no data on the clinical pathway about how physicians follow the dementia guideline in the routine practice.
Therefore, research is needed to learn clinical diagnostic process and treatment patterns of physicians to people with AD in routine practice and help address the low accurate rate of AD clinical diagnosis and low anti-dementia drug prescription in the real world and support guideline development.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Anonymous. (2012). Clinical Pathway for Alzheimer's Disease in China (CPAD): A 8-week Multi-center Registry Study to Investigate AD Diagnostic Pattern in Chinese Local Real Clinical Practice. <em>Peking University</em>. https://clinicaltrials.gov/study/NCT01779310
Vancouver
Anonymous. Clinical Pathway for Alzheimer's Disease in China (CPAD): A 8-week Multi-center Registry Study to Investigate AD Diagnostic Pattern in Chinese Local Real Clinical Practice. Peking University. 2012.
BibTeX
@misc{anon2012Clinic,
title = {Clinical Pathway for Alzheimer's Disease in China (CPAD): A 8-week Multi-center Registry Study to Investigate AD Diagnostic Pattern in Chinese Local Real Clinical Practice},
author = {Anonymous},
journal = {Peking University},
year = {2012},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Istituto Auxologico Italiano 2023
Open access · US-GOV
Avanzamenti in Materia di Screening Cognitivo Telefonico
Second Affiliated Hospital of Nanchang University 2006
Open access · US-GOV
Phenotypic Age Acceleration (PhenoAgeAccel) for Joint Prediction of Disease Risk, Mortality Risk, Life Expectancy, and Disease-Free Healthspan in Major Chronic Diseases
IRCCS SYNLAB SDN 2024
Open access · US-GOV
Novel Neuroradiological Workflow for the Assisted DIAgnosis and Management of DEMentia with Artificial Intelligence
BMC Geriatrics 2014
Open access · CC-BY
Screening for frailty in primary care: a systematic review of the psychometric properties of the frailty index in community-dwelling older people
VA Office of Research and Development 2007
Open access · US-GOV
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
Journal of Inherited Metabolic Disease 2024
Open access · CC-BY